Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926236-05-000034
Filing Date
2005-03-28
Accepted
2005-03-28 16:19:26
Documents
11
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K YEAR ENDED DECEMBER 31, 2004 cli04q4.txt 10-K 227282
2 SUPPLY AGREEMENT exh10-32.txt EX-10.32 42367
3 TRADEMARK LICENSE AGREEMENT exh10-33.txt EX-10.33 23488
4 MANUFACTURING AGREEMENT exh10-34.txt EX-10.34 29422
5 SUBSIDIARIES exh21-1.txt EX-21.1 675
6 CONSENT exh23-1.txt EX-23.1 1294
7 CONSENT exh23-2.txt EX-23.2 1002
8 RULE 13A-14(A) CERTIFICATION exh31-1.txt EX-31.1 3309
9 RULE 13A-14(A) CERTIFICATION exh31-2.txt EX-31.2 3361
10 SECTION 906 CERTIFICATION exh32-1.txt EX-32.1 1269
11 SECTION 906 CERTIFICATION exh32-2.txt EX-32.2 1249
  Complete submission text file 0000926236-05-000034.txt   337540
Mailing Address 2001 WALNUT HILL LANE IRVING TX 75038
Business Address 2001 WALNUT HILL LANE IRVING TX 75038 972-518-1300
CARRINGTON LABORATORIES INC /TX/ (Filer) CIK: 0000718007 (see all company filings)

EIN.: 751435663 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10862 | Film No.: 05706860
SIC: 2834 Pharmaceutical Preparations